OSMUNDA Group is the leading clinical trial CRO and service provider of medical devices and pharmaceuticals. Founded in 2004, OSMUNDA has about 250 professionals and 11 subsidiaries in China (Guangzhou, Beijing, Shanghai, Chengdu, Shenzhen, Tianjin, Suzhou and Wuxi), Hong Kong, USA, and Germany.
OSMUNDA is ready to assist you with a comprehensive service chain and one-stop solutions in the technical, clinical and regulatory aspects of medical device industry, including clinical trials, global product registration and approval, biomedical data management and analysis, consultation and training.
We have established close partnerships with clinical sites, notified bodies, testing agencies, industrial associations, manufacturers, suppliers, distributors and investors in the medical device industry. Joining in our network rewards you immediate connections to various industry resources.
Our enormous professional resource database and multifunctional project management platform with independent intellectual property guarantee the efficient and confidential project operation for our clients. Over 2600 domestic and international medical device enterprises have entrusted us with their business goals.
Services for China market entry is our core business
Global team provides seamless communication between clients and Chinese authorities.
300 professionals in 11 offices can manage a clinical trial in multiple sites across the country.